Our results showed that DCA levels in serum were downregulated in patients with GBC, which could contribute to tumor formation by increasing m6A modification level of pri-miR-92b, which targeted PTEN gene and promoted PI3K/AKT pathway signaling. This evidence concerns the gene AKT1 and neoplasm.